Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | SQLE | Q14534 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.40 |
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 2/20 | 0.38 |
| ▸ | FNTB | P49356 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18034096 | 1.00 | CYP3A4 (0.51) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18022139 | 1.00 | CYP3A4 (0.51) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18022145 | 0.92 | ALDH1A1 (0.43) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18034099 | 0.91 | ALDH1A1 (0.43) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18022156 | 0.90 | LMNA (0.42) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18034094 | 0.90 | LMNA (0.42) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18034140 | 0.87 | LMNA (0.47) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18022141 | 0.87 | LMNA (0.47) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL18034101 | 0.86 | KDM1A (0.46) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 | |
| SCHEMBL17826331 | 0.85 | LMNA (0.35) | CYP3A4ALOX15ALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160237012-A1 | ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF | GOLDEN BIOTECHNOLOGY CORPORATION | 2016-08-18 | — | — | US | disclosed |
| US-20160237012-A1 | ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF | GOLDEN BIOTECHNOLOGY CORPORATION | 2016-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237012-A1 | ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF | MCL1, HCCS, CASP3 | CYP3A4 185/4885ALOX15 837/4885ALDH1A1 1506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.